US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist
  • 11.870
  • +0.270+2.33%
Close Dec 23 16:00 ET
  • 11.870
  • 0.0000.00%
Post 16:45 ET
691.16MMarket Cap-4.18P/E (TTM)

Cullinan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cullinan Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Cullinan Therapeutics Earnings Reports

  • Cullinan Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:23 ET

  • Cullinan Therapeutics | 8-K: Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

    Nov 7 07:08 ET

  • Cullinan Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:24 ET

  • Cullinan Therapeutics | 8-K: Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

    Aug 8 07:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 16, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data